메뉴 건너뛰기




Volumn 81, Issue , 2014, Pages 32-36

Comparison between botulinum neurotoxin type A2 and type A1 by electrophysiological study in healthy individuals

Author keywords

A2NTX; Botulinum neurotoxin; CMAP; EDB test

Indexed keywords

BOTULINUM TOXIN A;

EID: 84894287591     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2013.12.012     Document Type: Article
Times cited : (17)

References (24)
  • 1
    • 77958501111 scopus 로고    scopus 로고
    • Effects of A2 type botulinum toxin on spontaneous miniature and evoked transmitter release from the rat spinal excitatory and inhibitory synapses
    • N. Akaike, Y. Ito, M.C. Shin, K. Nonaka, Y. Torii, T. Harakawa, A. Ginnaga, S. Kozaki, and R. Kaji Effects of A2 type botulinum toxin on spontaneous miniature and evoked transmitter release from the rat spinal excitatory and inhibitory synapses Toxicon 56 8 2010 1315 1326
    • (2010) Toxicon , vol.56 , Issue.8 , pp. 1315-1326
    • Akaike, N.1    Ito, Y.2    Shin, M.C.3    Nonaka, K.4    Torii, Y.5    Harakawa, T.6    Ginnaga, A.7    Kozaki, S.8    Kaji, R.9
  • 2
    • 34548307281 scopus 로고    scopus 로고
    • Comparison of Botulinum Neurotoxin Preparations for the Treatment of Cervical Dystonia
    • DOI 10.1016/j.clinthera.2007.07.020, PII S0149291807002123
    • M.A. Chapman, R. Barron, D.C. Tanis, C.E. Gill, and P.D. Charles Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia Clin. Ther. 29 7 2007 1325 1337 (Pubitemid 47348118)
    • (2007) Clinical Therapeutics , vol.29 , Issue.7 , pp. 1325-1337
    • Chapman, M.A.1    Barron, R.2    Tanis, D.C.3    Gill, C.E.4    Charles, P.D.5
  • 3
    • 72849120235 scopus 로고    scopus 로고
    • ®: Long term results
    • ®: long term results Eur. J. Neurol. 16 Suppl. 2 2009 2 5
    • (2009) Eur. J. Neurol. , vol.16 , Issue.SUPPL. 2 , pp. 2-5
    • Dressler, D.1
  • 4
    • 0028131916 scopus 로고
    • Serial neurophysiological studies of intramuscular botulinum-A toxin in humans
    • DOI 10.1002/mus.880171207
    • J.A. Hamjian, and F.O. Walker Serial neurophysiological studies of intramuscular botulinum-A toxin in humans Muscle Nerve 17 12 1994 1385 1392 (Pubitemid 24362810)
    • (1994) Muscle and Nerve , vol.17 , Issue.12 , pp. 1385-1392
    • Hamjian, J.A.1    Walker, F.O.2
  • 5
    • 20944432519 scopus 로고    scopus 로고
    • Efficacy and tolerability of a botulinum toxin type a free of complexing proteins (NT 201) compared with commercially available botulinum toxin type a (BOTOX®) in healthy volunteers
    • DOI 10.1007/s00702-004-0234-8
    • ®) in healthy volunteers J. Neural. Transm. 112 7 2005 905 913 (Pubitemid 40869079)
    • (2005) Journal of Neural Transmission , vol.112 , Issue.7 , pp. 905-913
    • Jost, W.H.1    Kohl, A.2    Brinkmann, S.3    Comes, G.4
  • 6
    • 0030614321 scopus 로고    scopus 로고
    • The EDB test - A clinical test for the detection of antibodies to botulinum toxin type A
    • DOI 10.1002/mds.870120116
    • K.R. Kessler, and R. Benecke The EBD test - a clinical test for the detection of antibodies to botulinum toxin type A Mov. Disord. 12 1 1997 95 99 (Pubitemid 27032886)
    • (1997) Movement Disorders , vol.12 , Issue.1 , pp. 95-99
    • Kessler, K.R.1    Benecke, R.2
  • 7
    • 0021181880 scopus 로고
    • Principles and pitfalls of nerve conduction studies
    • J. Kimura Principles and pitfalls of nerve conduction studies Ann. Neurol. 16 4 1984 415 429 (Pubitemid 14021820)
    • (1984) Annals of Neurology , vol.16 , Issue.4 , pp. 415-429
    • Kimura, J.1
  • 9
    • 0033911430 scopus 로고    scopus 로고
    • F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: Multicentre analysis in healthy subjects and patients with diabetic polyneuropathy
    • N. Kohara, J. Kimura, R. Kaji, Y. Goto, J. Ishii, M. Takiguchi, and M. Nakai F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicenter analysis in healthy subjects and patients with diabetic polyneuropathy Diabetologia 43 7 2000 915 921 (Pubitemid 30463172)
    • (2000) Diabetologia , vol.43 , Issue.7 , pp. 915-921
    • Kohara, N.1    Kimura, J.2    Kaji, R.3    Goto, Y.4    Ishii, J.5    Takiguchi, M.6    Nakai, M.7
  • 10
    • 74049135356 scopus 로고    scopus 로고
    • Repeatability of nerve conduction measurements derived entirely by computer methods
    • 10.1186/1475-925X-8-33
    • X. Kong, E.A. Lesser, and S.N. Gozani Repeatability of nerve conduction measurements derived entirely by computer methods Biomed. Eng. Online 8 2009 33 10.1186/1475-925X-8-33
    • (2009) Biomed. Eng. Online , vol.8 , pp. 33
    • Kong, X.1    Lesser, E.A.2    Gozani, S.N.3
  • 11
    • 0028824899 scopus 로고
    • Immunological characterization of the neurotoxin produced by Clostridium botulinum type A associated with infant botulism in Japan
    • S. Kozaki, S. Nakaue, and Y. Kamata Immunological characterization of the neurotoxin produced by Clostridium botulinum type A associated with infant botulism in Japan Microbiol. Immunol. 39 10 1995 767 774
    • (1995) Microbiol. Immunol. , vol.39 , Issue.10 , pp. 767-774
    • Kozaki, S.1    Nakaue, S.2    Kamata, Y.3
  • 12
    • 27744451445 scopus 로고    scopus 로고
    • Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin
    • DOI 10.1099/mic.0.28421-0
    • J.C. Lee, K. Yokota, H. Arimitsu, H.J. Hwang, Y. Sakaguchi, J. Cui, K. Takeshi, T. Watanabe, T. Ohyama, and K. Oguma Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin Microbiology 151 Pt 11 2005 3739 3747 (Pubitemid 41632084)
    • (2005) Microbiology , vol.151 , Issue.11 , pp. 3739-3747
    • Lee, J.-C.1    Yokota, K.2    Arimitsu, H.3    Hwang, H.-J.4    Sakaguchi, Y.5    Cui, J.6    Takeshi, K.7    Watanabe, T.8    Ohyama, T.9    Oguma, K.10
  • 14
    • 0028018244 scopus 로고
    • Measurement of botulinum toxin activity: Evaluation of the lethality assay
    • DOI 10.1006/taap.1994.1181
    • L.B. Pearce, G.E. Borodic, E.R. First, and R.D. MacCallum Measurement of botulinum toxin activity: evaluation of the lethality assay Toxicol. Appl. Pharmacol. 128 1 1994 69 77 (Pubitemid 24289132)
    • (1994) Toxicology and Applied Pharmacology , vol.128 , Issue.1 , pp. 69-77
    • Pearce, L.B.1    Borodic, G.E.2    First, E.R.3    MacCallum, R.D.4
  • 16
    • 33645099746 scopus 로고    scopus 로고
    • Pharmacology of botulinum toxin: Differences between type A preparations
    • R.L. Rosales, H. Bigalke, and D. Dressler Pharmacology of botulinum toxin: differences between type A preparations Eur. J. Neurol. 13 Suppl. 1 2006 2 10
    • (2006) Eur. J. Neurol. , vol.13 , Issue.SUPPL. 1 , pp. 2-10
    • Rosales, R.L.1    Bigalke, H.2    Dressler, D.3
  • 17
    • 3242680021 scopus 로고
    • Purification and oral toxicities of Clostridium botulinum progenitor toxins
    • G.E. Lewis, Academic Press New York
    • G. Sakaguchi, I. Ohishi, and S. Kozaki Purification and oral toxicities of Clostridium botulinum progenitor toxins G.E. Lewis, Biomedical Aspects of Botulism 1981 Academic Press New York 21 34
    • (1981) Biomedical Aspects of Botulism , pp. 21-34
    • Sakaguchi, G.1    Ohishi, I.2    Kozaki, S.3
  • 18
    • 0025603668 scopus 로고
    • Distinct characters of Clostridium botulinum type A strains and their toxin associated with infant botulism in Japan
    • G. Sakaguchi, S. Sakaguchi, Y. Kamata, K. Tabita, T. Asao, and S. Kozaki Distinct characters of Clostridium botulinum type A strains and their toxin associated with infant botulism in Japan Int. J. Food Microbiol. 11 3-4 1990 231 241
    • (1990) Int. J. Food Microbiol. , vol.11 , Issue.34 , pp. 231-241
    • Sakaguchi, G.1    Sakaguchi, S.2    Kamata, Y.3    Tabita, K.4    Asao, T.5    Kozaki, S.6
  • 19
    • 68949131091 scopus 로고    scopus 로고
    • Quantitative determination of the biological activity of botulinum toxin type A by measuring the compound muscle action potential (CMAP) in rats
    • T. Sakamoto, Y. Torii, M. Takahashi, S. Ishida, Y. Goto, H. Nakano, T. Harakawa, A. Ginnaga, S. Kozaki, and R. Kaji Quantitative determination of the biological activity of botulinum toxin type A by measuring the compound muscle action potential (CMAP) in rats Toxicon 54 6 2009 857 861
    • (2009) Toxicon , vol.54 , Issue.6 , pp. 857-861
    • Sakamoto, T.1    Torii, Y.2    Takahashi, M.3    Ishida, S.4    Goto, Y.5    Nakano, H.6    Harakawa, T.7    Ginnaga, A.8    Kozaki, S.9    Kaji, R.10
  • 20
    • 0030009918 scopus 로고    scopus 로고
    • Dose-response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A
    • R.R. Sloop, R.O. Escutin, J.A. Matus, B.A. Cole, and G.W. Peterson Dose-response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A Neurology 46 5 1996 1382 1386 (Pubitemid 26164651)
    • (1996) Neurology , vol.46 , Issue.5 , pp. 1382-1386
    • Sloop, R.R.1    Escutin, R.O.2    Matus, J.A.3    Cole, B.A.4    Peterson, G.W.5
  • 21
    • 0016678458 scopus 로고
    • Molecular construction of Clostridium botulinum type A toxins
    • S. Sugii, and G. Sakaguchi Molecular construction of Clostridium botulinum type A toxins Infect. Immun. 12 1975 1262 1270
    • (1975) Infect. Immun. , vol.12 , pp. 1262-1270
    • Sugii, S.1    Sakaguchi, G.2
  • 23
    • 34147222256 scopus 로고    scopus 로고
    • Neurophysiological double-blind trial of a botulinum neurotoxin type A free of complexing proteins
    • DOI 10.1097/01.WNF.0000240951.18821.50, PII 0000282620070300000003
    • K. Wohlfarth, C. Müller, I. Sassin, G. Comes, and S. Grafe Neurophysiological double-blind trial of a botulinum neurotoxin type a free of complexing proteins Clin. Neuropharmacol. 30 2 2007 86 94 (Pubitemid 46581201)
    • (2007) Clinical Neuropharmacology , vol.30 , Issue.2 , pp. 86-94
    • Wohlfarth, K.1    Muller, C.2    Sassin, I.3    Comes, G.4    Grafe, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.